{"id":3978,"date":"2023-06-27T14:52:43","date_gmt":"2023-06-27T14:52:43","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/do-current-therapies-target-kidney-inflammation\/"},"modified":"2026-01-22T17:27:34","modified_gmt":"2026-01-22T17:27:34","slug":"do-current-therapies-target-kidney-inflammation","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/","title":{"rendered":"Do current therapies target kidney inflammation?"},"content":{"rendered":"<p class=\"contentpasted0\"><span style=\"color: #006aab;\">At Sygnature Discovery, we specialise in the testing of anti-inflammatory therapies in our validated ex vivo and in vivo models.<\/span><\/p>\n<p class=\"contentpasted0\"><span style=\"color: black;\">\u00a0<\/span><\/p>\n<p class=\"contentpasted0\">Inflammation in the diseased kidney not only leads to progressive loss of kidney function but also contributes to the development of cardiovascular complications, increasing the risk of heart disease. However, there is a limited number of therapies available to target this specific aspect.<\/p>\n<p>While current therapies may slow down the progression of kidney disease, they do not effectively counteract the underlying triggers. It is important to raise awareness that anti-inflammatory therapeutics hold promise as our primary line of defence against kidney disease.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":2634,"template":"","category":[740,752,685,737,688],"class_list":["post-3978","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-ex-vivo-tissue-analysis","category-ii","category-in-vivo-pharmacology","category-inflammation-immunology-models","category-therapeutic-areas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Do current therapies target kidney inflammation? | Poster<\/title>\n<meta name=\"description\" content=\"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Do current therapies target kidney inflammation? | Poster\" \/>\n<meta property=\"og:description\" content=\"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T17:27:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/WCP-2023-WP-v5-no-1417.png\" \/>\n\t<meta property=\"og:image:width\" content=\"6622\" \/>\n\t<meta property=\"og:image:height\" content=\"9362\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/\",\"name\":\"Do current therapies target kidney inflammation? | Poster\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WCP-2023-WP-v5-no-1417.png\",\"datePublished\":\"2023-06-27T14:52:43+00:00\",\"dateModified\":\"2026-01-22T17:27:34+00:00\",\"description\":\"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WCP-2023-WP-v5-no-1417.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/WCP-2023-WP-v5-no-1417.png\",\"width\":6622,\"height\":9362},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/do-current-therapies-target-kidney-inflammation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Do current therapies target kidney inflammation?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"alternateName\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/@sygnature.discovery\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sygnature-discovery\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Do current therapies target kidney inflammation? | Poster","description":"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/","og_locale":"fr_CA","og_type":"article","og_title":"Do current therapies target kidney inflammation? | Poster","og_description":"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T17:27:34+00:00","og_image":[{"width":6622,"height":9362,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/WCP-2023-WP-v5-no-1417.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/","name":"Do current therapies target kidney inflammation? | Poster","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/WCP-2023-WP-v5-no-1417.png","datePublished":"2023-06-27T14:52:43+00:00","dateModified":"2026-01-22T17:27:34+00:00","description":"Kidney therapies slow disease progression but miss inflammatory triggers. Sygnature tests anti-inflammatory agents in ex vivo and in vivo models.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/WCP-2023-WP-v5-no-1417.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/WCP-2023-WP-v5-no-1417.png","width":6622,"height":9362},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/do-current-therapies-target-kidney-inflammation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Do current therapies target kidney inflammation?"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","alternateName":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@sygnature.discovery","https:\/\/www.linkedin.com\/company\/sygnature-discovery\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3978\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2634"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=3978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=3978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}